| |
| |
|
| Insider
Information: |
Westphal Christoph H |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
6,222,903 |
|
|
Indirect Shares
|
9,212,891 |
|
|
| Direct
Value |
$5,769,800 |
|
|
|
Indirect Value
|
$371,729,530 |
|
|
| Total
Shares |
15,435,794 |
|
|
| Total
Value |
$377,499,330 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2004-06-25 |
0 |
2004-06-25 |
76,648 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director, 10% Owner |
2004-05-27 |
0 |
2004-06-03 |
2,409,970 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Executive Chairman, Di... |
2015-06-30 |
665,224 |
2015-06-30 |
1,500,063 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director, 10% Owner |
2014-03-07 |
701,927 |
2014-03-07 |
3,825,421 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
10% Owner |
2018-10-16 |
3,941,118 |
2018-10-16 |
0 |
Premium* |
|
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
2021-07-20 |
914,634 |
2021-07-20 |
1,400,789 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2016-03-22 |
4/A |
B |
$11.78 |
$282,143 |
I/I |
23,951 |
2,910,955 |
2.64 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2016-03-23 |
4 |
B |
$11.55 |
$292,862 |
I/I |
25,356 |
2,936,311 |
2.64 |
- |
|
| VSTM |
Verastem, Inc. |
Chief Executive Officer |
• • • |
2013-03-12 |
4 |
D |
$9.37 |
$345,416 |
D/D |
(36,864) |
703,731 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2016-03-21 |
4 |
B |
$11.70 |
$564,195 |
I/I |
48,058 |
2,910,955 |
2.64 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2016-03-11 |
4 |
B |
$7.00 |
$627,760 |
I/I |
89,680 |
2,786,944 |
2.64 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-03-07 |
4 |
B |
$10.00 |
$1,000,000 |
I/I |
100,000 |
3,820,571 |
2.25 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2004-06-25 |
4 |
B |
$6.50 |
$1,040,000 |
I/I |
160,000 |
76,648 |
2.1 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • • |
2004-05-27 |
4 |
B |
$6.00 |
$1,875,000 |
I/I |
312,500 |
300,170 |
2.25 |
- |
|
| TCRX |
Tscan Therapeutics, Inc. |
10% Owner |
– – • |
2021-07-20 |
4 |
B |
$15.00 |
$1,999,995 |
I/I |
133,333 |
1,278,838 |
1.5 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
10% Owner |
– – • |
2018-10-16 |
4 |
S |
$0.92 |
$2,941,053 |
I/I |
(3,212,861) |
0 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
President and CEO |
• • • |
2012-02-01 |
4 |
A |
$10.00 |
$6,000,000 |
I/I |
600,000 |
2,869,841 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Executive Chairman |
• • – |
2015-01-28 |
4 |
B |
$6.50 |
$7,999,999 |
I/I |
1,230,769 |
1,230,769 |
2.66 |
- |
|
137 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
